May 21, 2026 · Form 4 insider transaction
Dambkowski Carl bought 38,689 shares of Oruka Therapeutics, Inc. at $6.84 per share, a transaction worth $264.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.